ClinicalTrials.Veeva

Menu

Effect of Transcutaneous Auricular Stimulation of the Vagus Nerve on Functional Connectivity in the Brain at Rest (COVAGNIRS)

C

Clinique Les Trois Soleils

Status

Enrolling

Conditions

Chronic Stroke Patients

Treatments

Device: Active taVNS arm
Device: Sham Control arm

Study type

Interventional

Funder types

Other

Identifiers

NCT07282106
2025-A01694-45
25.03521.000408 (Registry Identifier)

Details and patient eligibility

About

The goal of this clinical trial is to study the effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on resting-state brain functional connectivity. The study will assess this effect using functional Near-Infrared Spectroscopy (fNIRS) in both chronic post-stroke patients and healthy subjects.

The main questions it aims to answer are:

Does taVNS affect resting-state functional connectivity (measured by fNIRS) in chronic post-stroke patients?

Does taVNS affect resting-state functional connectivity (measured by fNIRS) in healthy subjects?

Are there differences in the effect of taVNS on functional connectivity between the post-stroke group and the healthy group?

Researchers will compare the effect of active taVNS (real stimulation) to a sham stimulation (control) to evaluate its specific impact on the brain's functional networks.

Enrollment

84 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for post-stroke participant:

  • age 18 or older
  • Right-handed participant;
  • Hemiparesis in the chronic phase (>6 months post-stroke)
  • Participant who has agreed to sign an informed consent form;
  • Participant who is affiliated with social security.

Inclusion Criteria for healthy participant:

  • age 18 or older
  • Right-handed participant;
  • Participant who has agreed to sign an informed consent form;
  • Participant who is affiliated with social security.

Exclusion Criteria for post-stroke participant:

  • Allergy to neoprene (the material used to make the fNIRS cap);
  • Hair volume preventing the cap from being put on and/or access to the scalp;
  • Cognitive impairment making it impossible to participate in the study;
  • Phasic disorders preventing understanding of instructions and effective communication;
  • Pregnant or breastfeeding women;
  • Persons under legal protection

Exclusion Criteria for post-stroke participant:

  • Allergy to neoprene (the material used to make the fNIRS cap);
  • Hair volume preventing the cap from being put on and/or access to the scalp;
  • Pregnant or breastfeeding women;
  • Persons under legal protection

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

84 participants in 2 patient groups

Active taVNS arm
Experimental group
Description:
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): Delivery of low-intensity electrical impulses to the outer ear (concha and tragus) to stimulate the auricular branch of the vagus nerve.
Treatment:
Device: Active taVNS arm
Sham Control arm
Sham Comparator group
Description:
Simulated/Placebo Stimulation (Sham): Application of the device without delivering an active electrical current, serving as the necessary control condition.
Treatment:
Device: Sham Control arm

Trial contacts and locations

1

Loading...

Central trial contact

Christophe DURET, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems